We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Genetic Testing Identifies Greater Inherited Sudden Cardiac Arrest Risk in Younger Individuals

By LabMedica International staff writers
Posted on 23 May 2026

Sudden cardiac arrest (SCA) is a frequently fatal electrical failure of the heart that is difficult to predict, as most victims have no prior warning signs. More...

Detecting inherited risk remains challenging, especially in individuals without obvious structural heart disease. A better understanding of how genetic susceptibility varies by age could help refine testing strategies for at-risk families. A new study shows that pathogenic variants associated with SCA are more common in younger individuals than in older adults.

Cedars-Sinai Medical Center’s Smidt Heart Institute (Los Angeles, CA, USA) analyzed the genetic architecture of SCA using whole genome sequencing (WGS) of individuals who experienced the event. WGS is a method that maps a person’s entire genetic code, enabling systematic detection of rare, damaging variants. The research highlights the need for broad genetic assessment to identify individuals and families at elevated risk.

The team examined blood samples from more than 3,000 people with SCA drawn from two community-based cohorts: the ongoing Oregon Sudden Unexpected Death Study and the Ventura Prediction of Sudden Death in Multi-Ethnic Communities study, spanning Portland, Oregon, and Ventura County, California. Investigators focused on rare, deleterious variants across 15 genes in which loss of normal function can increase the likelihood of SCA. They report that the prevalence of damaging variants decreases progressively with age.

Pathogenic variants were detected in 10% of individuals aged 29 years and younger, 7% of those 30–49 years, 4% of those 50–69 years, and 3% of those 70 years and older. In older adults, SCA more commonly reflects coronary artery narrowing or occlusion rather than a primary genetic arrhythmia substrate, according to the investigators. The authors note that SCA is fatal in 90% of cases. Findings were published in JACC: Clinical Electrophysiology, and the investigators indicated that additional research could uncover further genes implicated in SCA.

“If you have a family member who suffered sudden cardiac arrest, it is important to undergo genetic testing to determine if you harbor a genetic variant that increases your risk of sudden cardiac arrest or other heart conditions. For people who carry a variant linked to sudden cardiac arrest, a cardiologist can prescribe medications or lifestyle changes that can decrease the chances of experiencing this dangerous event,” said Evan Kransdorf, MD, Ph.D., assistant professor of Cardiology in the Smidt Heart Institute and first author of the study.

“This study is more representative of the U.S. population than other studies because it includes data from two communities rather than data from people already being seen at a medical center,” said Sumeet Chugh, MD, director of the Center for Cardiac Arrest Prevention at the Smidt Heart Institute and senior author of the study.

Related Links
Cedars-Sinai Medical Center’s Smidt Heart Institute


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette Calibration System
Artel PCS®
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.